Dan Smetana will be retiring as non-executive director of Korab Resources at the start of next year. Mr Smetana has been with the company since 2013.
Dr Michael Baker has been appointed chief executive of SUDA Pharmaceuticals and will commence in the role in January 2020. Dr Baker was investment manager of Australian life science fund, Bioscience Managers, and was responsible for deal sourcing from networks, conferences, universities and research institutes. He will take over from Paul Hopper, who will step down as executive chair but remains on the board as non-executive chair.
Xstate Resources has appointed Richard Lorentz as non-executive director and David McArthur as interim managing director. Mr Lorentz is a petroleum geologist and a leading member of the upstream oil and gas community in Southeast Asia. Mr McArthur was a non-executive director until July this year and will be re-joining the board as interim managing director while the company searches for a managing director following the resignation of Cosimo Damiano. Ian Tchacos has also resigned as non-executive director.
